glp 1 new indications The expanding benefits of GLP-1 medicines: Cell Reports Medicine GLP-1 Agonists Market Report 2025-2033,
Description
Probably the game-changing study in the New England Journal, which I was corresponding author on, was STEP 1, which actually launched semaglutide to the world which for the first time caused a result in a 15% weight loss at the end of a year

You might NOT be able to take GLP-1 if you have a history of pancreatitis, kidney disease/kidney insufficiency, Stomach problems, diabetes (must be approved from endocrinologist) or gall bladder disease

Chromium picolinate Chromium is a trace mineral that has been studied extensively for its role in glucose metabolism and insulin sensitivity

doi: 10.1016/j.diabres.2021.109080

The brains gate control theory suggests that signals of anxiety or stress can actually open the gate to pain signals, making a minor sensation feel much more intense

doi: 10.1210/endo.133.1.8319572 [DOI] [PubMed] [Google Scholar] 47
